IMATINIB

imatinib 400 mg tablet, 30

IMATINIB (9179D)

imatinib 400 mg tablet, 30
9179D
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Aggressive systemic mastocytosis with eosinophilia
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $189.48 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Gilmat
Glivec
IMATINIB RBX
Imanib
Imatinib Sandoz
Imatinib-Teva